How Rising Cancer Immunotherapy Demand and Genetic Engineering Advancements Are Driving the Chimeric Fusion Protein Market
The global Chimeric Fusion Protein market is expanding as healthcare providers, pharmaceutical companies, and research institutions invest in advanced therapeutic solutions to address the rising incidence of cancer and improve patient outcomes. The market was valued at USD 21.31 billion in 2023 and is projected to reach USD 85.4 billion by 2032, growing at a CAGR of 16.68%. The Chimeric Fusion...
0 Comments 0 Shares 78 Views 0 Reviews